NMR methods in fragment screening: theory and a comparison with other biophysical techniques

被引:120
作者
Dalvit, Claudio [1 ,2 ]
机构
[1] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland
[2] Italian Inst Technol, Dept Drug Discovery & Dev, I-16163 Genoa, Italy
关键词
SURFACE-PLASMON RESONANCE; HIGH-AFFINITY LIGANDS; FLUORESCENCE LIFETIME; DRUG DESIGN; LEAD GENERATION; BETA-SECRETASE; BINDING; DISCOVERY; POLARIZATION; PERSPECTIVES;
D O I
10.1016/j.drudis.2009.07.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nuclear magnetic resonance, surface plasmon resonance and fluorescence spectroscopy (particularly fluorescence anisotropy and fluorescence lifetime) are techniques often applied to fragment screening. These methodologies are analyzed on the basis of their performance, strengths, limitations and pitfalls. NMR-based screening, despite its low intrinsic sensitivity, offers the largest dynamic range and is capable of capturing very weak interactions. Theoretical simulation demonstrates the power of some NMR experiments, in particular those with fluorine observation, in detecting protein interactions for fragments tested at concentrations orders of magnitude lower than their dissociation binding constants. This apparently counterintuitive finding enables the identification of hits that are insoluble at the concentrations required for detection by other biophysical techniques. However it is evident that several techniques should be applied and the data analyzed on the basis of their complementarities.
引用
收藏
页码:1051 / 1057
页数:7
相关论文
共 52 条
[1]   Ligand efficiency indices as guideposts for drug discovery [J].
Abad-Zapatero, C ;
Metz, JT .
DRUG DISCOVERY TODAY, 2005, 10 (07) :464-469
[2]  
[Anonymous], [No title captured]
[3]  
Bartoli S., 2006, DRUG DISCOV TODAY TE, V3, P425, DOI DOI 10.1016/J.DDTEC.2006.12.001
[4]   Recent developments in fragment-based drug discovery [J].
Congreve, Miles ;
Chessari, Gianni ;
Tisi, Dominic ;
Woodhead, Andrew J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (13) :3661-3680
[5]   Optical biosensors in drug discovery [J].
Cooper, MA .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) :515-528
[6]   Identification of compounds with binding affinity to proteins via magnetization transfer from bulk water [J].
Dalvit, C ;
Pevarello, P ;
Tatò, M ;
Veronesi, M ;
Vulpetti, A ;
Sundström, M .
JOURNAL OF BIOMOLECULAR NMR, 2000, 18 (01) :65-68
[7]   Fluorine-NMR experiments for high-throughput screening: Theoretical aspects, practical considerations, and range of applicability [J].
Dalvit, C ;
Fagerness, PE ;
Hadden, DTA ;
Sarver, RW ;
Stockman, BJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (25) :7696-7703
[8]   Theoretical analysis of the competition ligand-based NMR experiments and selected applications to fragment screening and binding constant measurements [J].
Dalvit, Claudio .
CONCEPTS IN MAGNETIC RESONANCE PART A, 2008, 32A (05) :341-372
[9]   Ligand- and substrate-based 19F NMR screening:: Principles and applications to drug discovery [J].
Dalvit, Claudio .
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY, 2007, 51 (04) :243-I
[10]   Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency [J].
Edwards, Philip D. ;
Albert, Jeffrey S. ;
Sylvester, Mark ;
Aharony, David ;
Andisik, Donald ;
Callaghan, Owen ;
Campbell, James B. ;
Carr, Robin A. ;
Chessari, Gianni ;
Congreve, Miles ;
Frederickson, Martyn ;
Folmer, Rutger H. A. ;
Geschwindner, Stefan ;
Koether, Gerard ;
Kolmodin, Karin ;
Krumrine, Jennifer ;
Mauger, Russell C. ;
Murray, Christopher W. ;
Olsson, Lise-Lotte ;
Patel, Sahil ;
Spear, Nate ;
Tian, Gaochao .
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (24) :5912-5925